• Tomivosertib: A Translation-Focused GBM Strategy

  2026-08-29

  Tomivosertib is a potent MNK1 inhibitor for dissecting eIF4E-dependent translation in glioblastoma models. This article develops an assay-centered framework that connects tumor-cell survival, endothelial angiogenesis, chemotherapy response, and pathway-specific interpretation.

• Toremifene Citrate: Evidence and Clinical Translation

  2026-08-28

  The reference article presents Toremifene Citrate as a nonsteroidal antiestrogen and oral selective estrogen receptor modulator for postmenopausal patients with advanced hormone receptor-positive or unknown-status breast cancer. Its main contribution is an implementation-focused synthesis linking receptor pharmacology, comparative efficacy with tamoxifen, metabolism, safety monitoring, drug interactions, and patient-management considerations.

• EZ Cap™ OVA mRNA: Designing Cleaner Immune Assays

  2026-08-28

  EZ Cap™ OVA mRNA provides a defined Cap 1-capped Ovalbumin mRNA template for interpretable immune, expression, and vaccine studies. This article presents a delivery-aware framework for separating transcript quality from formulation and inflammatory variables.

• EZ Cap™ Cas9 mRNA for Causal Neurobiology

  2026-08-27

  Explore how EZ Cap™ Cas9 mRNA (5-moUTP) can support causal gene editing studies of Fyn–Stat3 neuroinflammation. This article connects mRNA design, transient CRISPR-Cas9 genome editing, and assay architecture for more rigorous zebrafish neurobiology research.

• Streptavidin-Cy3 for Super-Enhancer RNA Imaging

  2026-08-27

  Streptavidin-Cy3 converts biotinylated probes, antibodies, and nucleic acids into bright Cy3 signals for spatial studies of super-enhancer RNA and NDRG1-linked metastasis. This practical guide connects assay design, imaging, flow cytometry, and troubleshooting to the mechanistic findings reported in nasopharyngeal carcinoma research.

• BH4 Oxidation Links H2O2 to ERK1/2 in DRG Neurons

  2026-08-26

  The reference study identifies oxidation-derived H2O2, rather than BH4 itself, as the signal that increases ERK1/2 phosphorylation in rat dorsal root ganglion neurons. Its pharmacological data place B-Raf upstream of MEK1/2 and ERK1/2, revealing a potentially selective mechanism for studying BH4-associated nociceptor sensitization without broadly reducing BH4 levels.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-08-26

  The reference study identifies CD44 as a functional metabolic dependency in IDH-mutant leukemia, linking R-2HG-driven signaling to pentose phosphate pathway activation, glycolysis suppression, and sustained NADPH production. Its isogenic CRISPR design supports a model in which combined mutant IDH and CD44 pathway inhibition could address incomplete responses to IDH-directed therapy.

• Nifedipine (BAY-a-1040) Research Workflows

  2026-08-25

  Build controlled calcium-signaling, iron-transport, fungal, and liver-metabolism assays with Nifedipine (BAY-a-1040). This workflow guide separates established calcium channel applications from exploratory experiments inspired by PXR-driven liver regeneration and CYP induction.

• Phosphosignal Preservation in Fatty Liver Research

  2026-08-25

  Phosphorylation can define whether a liver sample reveals active signaling or an ex vivo artifact. This thought-leadership article connects the SREBP-1c–CSE/H2S–ULK1 axis in hepatic steatosis with disciplined lysate handling and shows how Phosphatase Inhibitor Cocktail 3 supports translational phosphoprotein analysis.

• AG-120 (Ivosidenib) AML Research Workflow

  2026-08-24

  Build a mechanism-led AML workflow around AG-120 (Ivosidenib), connecting mutant IDH1 inhibition to 2-hydroxyglutarate reduction, differentiation, and metabolic dependency assays. The design separates target engagement from nonspecific cytotoxicity and extends the reference study’s CD44 findings into practical combination-testing strategies.

• Ibrexafungerp Activity Against Resistant Candida auris

  2026-08-24

  Wiederhold and colleagues showed that ibrexafungerp retained in vitro activity against fluconazole-resistant Candida auris and improved outcomes in a neutropenic mouse model even when therapy began after infection was established. The study is important because it links an orally available glucan-synthase inhibitor to a delayed-treatment design that more closely reflects a clinically challenging invasive candidiasis scenario.

• Phosbind Acrylamide for Mechanistic Phospho Assays

  2026-08-23

  Phosbind Acrylamide enables antibody-free protein phosphorylation analysis through phosphate-dependent mobility shifts in SDS-PAGE. This article connects the assay principle to the OsSTRK1–OsGSK2 brassinosteroid study and explains how to distinguish screening evidence from site-specific mechanistic proof.

• PtrbZIP12 Links Drought Defense to PtrDHN and PtrPOD

  2026-08-22

  This study defines PtrbZIP12 as a positive regulator of drought tolerance in Populus trichocarpa and identifies PtrDHN and PtrPOD as direct transcriptional targets. By connecting promoter binding, ROS control, proline accumulation, and phosphorylation-dependent regulation, it provides a mechanistic framework for studying drought-responsive transcription factors in trees.

• Nitrocefin Workflow for β-Lactamase Assays

  2026-08-22

  Build a practical Nitrocefin workflow for rapid β-lactamase activity measurement, inhibitor screening, and resistance-mechanism studies. The guide connects colorimetric bench assays with the 2024 MDockPeP2_VS peptide-screening study while emphasizing controls, optimization, and interpretation limits.

• Isochlorogenic Acid A: From Molecule to Wound Assay

  2026-08-21

  Explore Isochlorogenic acid A (3,5-Dicaffeoylquinic acid) through its molecular properties, formulation constraints, and emerging wound-repair applications. This evidence-led guide translates a recent hydrogel study into practical decisions for natural product, anti-infection, immunology, and inflammation research.

8420 records 1/562 page Next 12345 下5页 Last page